Apexion Health Glutathione injection vial
LONGEVITYANTIOXIDANT

MONTHLY SUPPLY · INJECTION

GLUTATHIONE

TREATMENT

Master antioxidant for detoxification and immune health

SUPPORT

Glutathione is the body's most abundant intracellular antioxidant tripeptide. IV or IM administration bypasses poor oral bioavailability to deliver clinically relevant concentrations for oxidative stress reduction, immune support, and hepatoprotection.

Shop Now

Lab-Tested · Physician-Supervised · Discreet Delivery

Apexion Health — LONGEVITY

THE MASTER ANTIOXIDANT. DELIVERED DIRECTLY.

Glutathione (γ-L-glutamyl-L-cysteinyl-glycine) is synthesized in virtually every cell and serves as the primary intracellular defense against oxidative stress and xenobiotic toxins. It is essential for immune cell function, mitochondrial integrity, and hepatic phase II detoxification. Oral glutathione has poor bioavailability due to gastrointestinal hydrolysis; injectable administration delivers therapeutically significant plasma concentrations and is the clinically preferred route for systemic benefit.

Clinical Benefits

GLUTATHIONE SUPPORTS YOUR HEALTH AT THE CELLULAR LEVEL

  1. 01.

    NEUTRALIZES FREE RADICALS AND REACTIVE OXYGEN SPECIES

  2. 02.

    SUPPORTS HEPATIC PHASE II DETOXIFICATION PATHWAYS

  3. 03.

    ENHANCES NATURAL KILLER CELL AND T-CELL IMMUNE ACTIVITY

  4. 04.

    REGENERATES VITAMINS C AND E AS ANTIOXIDANT COFACTORS

  5. 05.

    SUPPORTS MITOCHONDRIAL MEMBRANE INTEGRITY

  6. 06.

    PHYSICIAN-PRESCRIBED INJECTABLE FOR MAXIMUM BIOAVAILABILITY

Shop Now

Clinical Evidence

How It Works in the Body

01 — Dose & Efficacy

Cellular Antioxidant Enhancement

Lipid Peroxidation MDA reduction in studies25%
ALT Improvement ~25% in NAFLD studies20%
GSH/GSSG Ratio Redox balance improvement35%

Richie et al., Eur J Nutr 2015; Allen & Bradley, Redox Biol 2018

02 — Hormone Panel

Oxidative Stress Markers

MarkerWithoutWith Treatment
Whole Blood GSHµmol/L
850
1105+30% (est.)
GSH/GSSG RatioRatio
15
22+7 (est.)
MDA (Lipid Perox.)µmol/L
1.8
1.35−25% (est.)
ALT (Liver)U/L
42
32−10 (est.)

Oral bioavailability is the key challenge

Standard oral GSH has poor bioavailability. Liposomal GSH and NAC (600–1200 mg/day) are better-studied. NAC reliably increases intracellular GSH synthesis. IV GSH bypasses absorption but limited RCT data.

Richie et al., Eur J Nutr 2015; Sinha et al., BMC Gastroenterol 2018

03 — Protocol

Glutathione Enhancement

BaselinePre-treatment
  • ›GSH level (specialized assay)
  • ›Liver function (ALT, AST, GGT)
  • ›Oxidative stress markers
LoadingWeeks 1–8
  • ›Liposomal GSH 500–1000 mg/day OR NAC 600–1200 mg/day
  • ›LFTs at 4 weeks
  • ›Tolerability & GI symptoms
MaintenanceMonth 3+
  • ›Adjust dose/form by response
  • ›LFTs & oxidative markers q3 months
  • ›IV option if oral insufficient

NAC is the most evidence-based GSH precursor

NAC 600–1200 mg/day reliably increases intracellular glutathione. Liposomal GSH has better oral bioavailability. IV GSH protocols exist but published evidence is thin.

All protocols physician-supervised and adjusted per individual labs.